Am J Epidemiol 2003; 157:1015-1022.
Copyright © 2003 by Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Incidence of Parkinson’s Disease: Variation by Age, Gender, and Race/Ethnicity
1 Division of Research, Kaiser Permanente, Oakland, CA.
2 The Parkinson’s Institute, Sunnyvale, CA.
3 Kaiser Santa Rosa Medical Center, Santa Rosa, CA.
4 Kaiser Hayward Medical Center, Hayward, CA.
5 Stanford University, Stanford, CA.
The goal of this study was to estimate the incidence of Parkinson’s disease by age, gender, and ethnicity. Newly diagnosed Parkinson’s disease cases in 1994–1995 were identified among members of the Kaiser Permanente Medical Care Program of Northern California, a large health maintenance organization. Each case met modified standardized criteria/Hughes diagnostic criteria as applied by a movement disorder specialist. Incidence rates per 100,000 person-years were calculated using the Kaiser Permanente membership information as the denominator and adjusted for age and/or gender using the direct method of standardization. A total of 588 newly diagnosed (incident) cases of Parkinson’s disease were identified, which gave an overall annualized age- and gender-adjusted incidence rate of 13.4 per 100,000 (95% confidence interval (CI): 11.4, 15.5). The incidence rapidly increased over the age of 60 years, with only 4% of the cases being under the age of 50 years. The rate for men (19.0 per 100,000, 95% CI: 16.1, 21.8) was 91% higher than that for women (9.9 per 100,000, 95% CI: 7.6, 12.2). The age- and gender-adjusted rate per 100,000 was highest among Hispanics (16.6, 95% CI: 12.0, 21.3), followed by non-Hispanic Whites (13.6, 95% CI: 11.5, 15.7), Asians (11.3, 95% CI: 7.2, 15.3), and Blacks (10.2, 95% CI: 6.4, 14.0). These data suggest that the incidence of Parkinson’s disease varies by race/ethnicity.
age factors; ethnic groups; incidence; Parkinson disease; racial stocks; sex
Abbreviations: Abbreviations: CI, confidence interval; KPMCP, Kaiser Permanente Medical Care Program.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. L. Cunningham, A. Giuffrida, and J. L. Roberts Androgens Induce Dopaminergic Neurotoxicity via Caspase-3-Dependent Activation of Protein Kinase C{delta} Endocrinology, December 1, 2009; 150(12): 5539 - 5548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Abou-Raya, M. Helmii, and A. Abou-Raya Bone and mineral metabolism in older adults with Parkinson's disease Age Ageing, November 1, 2009; 38(6): 675 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Y. Lo, C. M. Tanner, K. B. Albers, A. D. Leimpeter, R. D. Fross, A. L. Bernstein, V. McGuire, C. P. Quesenberry, L. M. Nelson, and S. K. Van Den Eeden Clinical Features in Early Parkinson Disease and Survival Arch Neurol, November 1, 2009; 66(11): 1353 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tisch and B. Brew PARKINSONISM IN HIV-INFECTED PATIENTS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY Neurology, August 4, 2009; 73(5): 401 - 403. [Full Text] [PDF]
|
|
|
|
 |
|
 M M Wickremaratchi, D Perera, C O'Loghlen, D Sastry, E Morgan, A Jones, P Edwards, N P Robertson, C Butler, H R Morris, et al. Prevalence and age of onset of Parkinson's disease in Cardiff: a community based cross sectional study and meta-analysis J. Neurol. Neurosurg. Psychiatry, July 1, 2009; 80(7): 805 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hattori, M. Swan, G. A. Stobbe, J. M. Uomoto, S. Minoshima, D. Djang, R. Krishnananthan, and D. H. Lewis Differential SPECT Activation Patterns Associated with PASAT Performance May Indicate Frontocerebellar Functional Dissociation in Chronic Mild Traumatic Brain Injury J. Nucl. Med., July 1, 2009; 50(7): 1054 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pitts, D. Bolser, J. Rosenbek, M. Troche, M. S. Okun, and C. Sapienza Impact of Expiratory Muscle Strength Training on Voluntary Cough and Swallow Function in Parkinson Disease Chest, May 1, 2009; 135(5): 1301 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Driver, G. Logroscino, J. M. Gaziano, and T. Kurth Incidence and remaining lifetime risk of Parkinson disease in advanced age Neurology, February 3, 2009; 72(5): 432 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Arnold, G. W. de Araujo, and C. Beyer Gender-specific regulation of mitochondrial fusion and fission gene transcription and viability of cortical astrocytes by steroid hormones J. Mol. Endocrinol., November 1, 2008; 41(5): 289 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Davidsdottir, R. Wagenaar, D. Young, and A. Cronin-Golomb Impact of optic flow perception and egocentric coordinates on veering in Parkinson's disease Brain, November 1, 2008; 131(11): 2882 - 2893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Chen, D. P. Trombetta, and H. H. Fernandez Palliative Management of Parkinson Disease: Focus on Nonmotor, Distressing Symptoms Journal of Pharmacy Practice, August 1, 2008; 21(4): 262 - 272. [Abstract] [PDF]
|
|
|
|
|
|
C. Marras, S. K. Van den Eeden, R. D. Fross, K. S. Benedict-Albers, J. Klingman, A. D. Leimpeter, L. M. Nelson, N. Risch, A. J. Karter, A. L. Bernstein, et al. Minimum incidence of primary cervical dystonia in a multiethnic health care population Neurology, August 14, 2007; 69(7): 676 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K S M Taylor, J A Cook, and C E Counsell Heterogeneity in male to female risk for Parkinson's disease J. Neurol. Neurosurg. Psychiatry, August 1, 2007; 78(8): 905 - 906. [Full Text] [PDF]
|
|
|
|
|
|
C. A Haaxma, B. R Bloem, G. F Borm, W. J G Oyen, K. L Leenders, S. Eshuis, J. Booij, D. E Dluzen, and M. W I M Horstink Gender differences in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, August 1, 2007; 78(8): 819 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ritz, A. Ascherio, H. Checkoway, K. S. Marder, L. M. Nelson, W. A. Rocca, G. W. Ross, D. Strickland, S. K. Van Den Eeden, and J. Gorell Pooled Analysis of Tobacco Use and Risk of Parkinson Disease Arch Neurol, July 1, 2007; 64(7): 990 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chaudhuri, K. Bowling, C. Funderburk, H. Lawal, A. Inamdar, Z. Wang, and J. M. O'Donnell Interaction of Genetic and Environmental Factors in a Drosophila Parkinsonism Model J. Neurosci., March 7, 2007; 27(10): 2457 - 2467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hirtz, D. J. Thurman, K. Gwinn-Hardy, M. Mohamed, A. R. Chaudhuri, and R. Zalutsky How common are the "common" neurologic disorders? Neurology, January 30, 2007; 68(5): 326 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Richardson, W. M. Caudle, M. Wang, E. D. Dean, K. D. Pennell, and G. W. Miller Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease FASEB J, August 1, 2006; 20(10): 1695 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Miyasaki, K. Shannon, V. Voon, B. Ravina, G. Kleiner-Fisman, K. Anderson, L. M. Shulman, G. Gronseth, and W. J. Weiner Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, April 11, 2006; 66(7): 996 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Glatt, A. D. Wahner, D. J. White, A. Ruiz-Linares, and B. Ritz Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women Hum. Mol. Genet., January 15, 2006; 15(2): 299 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Popat, S. K. Van Den Eeden, C. M. Tanner, V. McGuire, A. L. Bernstein, D. A. Bloch, A. Leimpeter, and L. M. Nelson Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease Neurology, August 9, 2005; 65(3): 383 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Ravina, M Putt, A Siderowf, J T Farrar, M Gillespie, A Crawley, H H Fernandez, M M Trieschmann, S Reichwein, and T Simuni Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study J. Neurol. Neurosurg. Psychiatry, July 1, 2005; 76(7): 934 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Chen, B. Cagniard, T. Mathews, S. Jones, H. C. Koh, Y. Ding, P. M. Carvey, Z. Ling, U. J. Kang, and X. Zhuang Age-dependent Motor Deficits and Dopaminergic Dysfunction in DJ-1 Null Mice J. Biol. Chem., June 3, 2005; 280(22): 21418 - 21426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Sturman, D. E. Vaillancourt, and D. M. Corcos Effects of Aging on the Regularity of Physiological Tremor J Neurophysiol, June 1, 2005; 93(6): 3064 - 3074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Van Raamsdonk, J. Pearson, D. A. Rogers, N. Bissada, A. W. Vogl, M. R. Hayden, and B. R. Leavitt Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease Hum. Mol. Genet., May 15, 2005; 14(10): 1379 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M.L. de Lau, P. C.L.M. Giesbergen, M. C. de Rijk, A. Hofman, P. J. Koudstaal, and M. M.B. Breteler Incidence of parkinsonism and Parkinson disease in a general population: The Rotterdam Study Neurology, October 12, 2004; 63(7): 1240 - 1244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Du, H. Bayir, Y. Lai, X. Zhang, P. M. Kochanek, S. C. Watkins, S. H. Graham, and R. S. B. Clark Innate Gender-based Proclivity in Response to Cytotoxicity and Programmed Cell Death Pathway J. Biol. Chem., September 10, 2004; 279(37): 38563 - 38570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Goldman, C. G. Goetz, E. Berry-Kravis, S. Leurgans, and L. Zhou Genetic Polymorphisms in Parkinson Disease Subjects With and Without Hallucinations: An Analysis of the Cholecystokinin System Arch Neurol, August 1, 2004; 61(8): 1280 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kumar, S. M. Calne, M. Schulzer, E. Mak, Z. Wszolek, C. Van Netten, J. K. C. Tsui, A. J. Stoessl, and D. B. Calne Clustering of Parkinson Disease: Shared Cause or Coincidence? Arch Neurol, July 1, 2004; 61(7): 1057 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chen, S. M. Zhang, M. A. Schwarzschild, M. A. Hernan, W. C. Willett, and A. Ascherio Obesity and the Risk of Parkinson's Disease Am. J. Epidemiol., March 15, 2004; 159(6): 547 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Benito-Leon, F. Bermejo-Pareja, J. M. Morales-Gonzalez, J. Porta-Etessam, R. Trincado, S. Vega, and E. D. Louis Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain Neurology, March 9, 2004; 62(5): 734 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Foltynie, C. E. G. Brayne, T. W. Robbins, and R. A. Barker The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study Brain, March 1, 2004; 127(3): 550 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Miyasaki, K. Shannon, V. Voon, B. Ravina, G. Kleiner-Fisman, K. Anderson, L. M. Shulman, G. Gronseth, and W. J. Weiner Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, April 11, 2006; 66(7): 996 - 1002. [Abstract] [Full Text] [PDF]
|
|